SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-10-142304
Filing Date
2010-06-18
Accepted
2010-06-18 16:38:25
Documents
14
Period of Report
2010-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 17827
2 UNDERWRITING AGREEMENT, DATED 6/15/10, BY TEVA PHARMACEUTICAL FINANCE II B.V. dex11.htm EX-1.1 146432
3 UNDERWRITING AGREEMENT, DATED 6/15/10, BY TEVA PHARMACEUTICAL FINANCE III, LLC dex12.htm EX-1.2 149577
4 SENIOR INDENTURE, DATED AS OF 6/18/10, BY TEVA PHARMACEUTICAL FINANCE III, LLC dex41.htm EX-4.1 321602
5 1ST SUPPLEMENTAL SENIOR INDENTURE DTD 6/18/10 BY TEVA PHARMACEUTICAL FINANCE III dex42.htm EX-4.2 270138
6 SENIOR INDENTURE, DATED AS OF 6/18/10, BY TEVA PHARMACEUTICAL FINANCE II B.V. dex43.htm EX-4.3 323571
7 1ST SUPPLEMENTAL SENIOR INDENTURE DTD 6/18/10-TEVA PHARMACEUTICAL FINANCE II B.V dex44.htm EX-4.4 209543
8 OPINION OF TULCHINSKY STERN MARCIANO COHEN LEVITSKY & CO. dex51.htm EX-5.1 11201
9 OPINION OF WILLKIE FARR & GALLAGHER LLP dex52.htm EX-5.2 18437
10 OPINION OF VANEPS KUNNEMAN VANDOORNE dex53.htm EX-5.3 45254
11 GRAPHIC g41123g51a53.jpg GRAPHIC 27512
12 GRAPHIC g41123g58t95.jpg GRAPHIC 27488
13 GRAPHIC g41123g94d84.jpg GRAPHIC 161994
14 GRAPHIC g41123willkie.jpg GRAPHIC 8387
  Complete submission text file 0001193125-10-142304.txt   1826138
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-16174 | Film No.: 10906220
SIC: 2834 Pharmaceutical Preparations